News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
152,557 Results
Type
Article (3144)
Company Profile (93)
Press Release (149320)
Section
Business (47551)
Career Advice (92)
Deals (8440)
Drug Delivery (3)
Drug Development (29369)
Employer Resources (12)
FDA (2391)
Job Trends (3216)
News (86524)
Policy (5634)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (151)
Accelerated approval (1)
Adcomms (5)
Allergies (27)
Alliances (10709)
ALS (30)
Alzheimer's disease (299)
Antibody-drug conjugate (ADC) (36)
Approvals (2433)
Artificial intelligence (36)
Autoimmune disease (7)
Bankruptcy (50)
Best Places to Work (2849)
BIOSECURE Act (2)
Biosimilars (26)
Biotechnology (63)
Bladder cancer (22)
Brain cancer (11)
Breast cancer (56)
Cancer (611)
Cardiovascular disease (36)
Career advice (83)
Career pathing (2)
CAR-T (43)
Cell therapy (99)
Cervical cancer (3)
Clinical research (25356)
Collaboration (213)
Compensation (278)
Complete response letters (3)
COVID-19 (360)
CRISPR (5)
C-suite (88)
Cystic fibrosis (20)
Data (742)
Depression (10)
Diabetes (56)
Diagnostics (318)
Diversity, equity & inclusion (2)
Drug discovery (22)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (14)
Earnings (21360)
Editorial (2)
Employer branding (1)
Employer resources (11)
Events (31363)
Executive appointments (250)
FDA (2715)
Featured Employer (17)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (150)
Gene editing (10)
Generative AI (1)
Gene therapy (34)
GLP-1 (135)
Government (377)
Grass and pollen (1)
Guidances (12)
Healthcare (1722)
Huntington's disease (5)
IgA nephropathy (7)
Immunology and inflammation (21)
Indications (13)
Infectious disease (383)
Inflammatory bowel disease (40)
Influenza (7)
Intellectual property (28)
Interviews (12)
IPO (5232)
IRA (2)
Job creations (508)
Job search strategy (77)
Kidney cancer (5)
Layoffs (33)
Legal (698)
Liver cancer (14)
Lung cancer (104)
Lymphoma (51)
Management (4)
Manufacturing (76)
MASH (33)
Medical device (300)
Medtech (300)
Mergers & acquisitions (3415)
Metabolic disorders (164)
Multiple sclerosis (28)
NASH (7)
Neurodegenerative disease (18)
Neuropsychiatric disorders (2)
Neuroscience (447)
NextGen: Class of 2025 (701)
Non-profit (183)
Northern California (1032)
Now hiring (3)
Obesity (74)
Opinion (15)
Ovarian cancer (24)
Pain (19)
Pancreatic cancer (14)
Parkinson's disease (37)
Patents (56)
Patient recruitment (41)
Peanut (15)
People (15022)
Pharmaceutical (32)
Phase I (7445)
Phase II (11541)
Phase III (8351)
Pipeline (424)
Policy (7)
Postmarket research (478)
Preclinical (2734)
Press Release (11)
Prostate cancer (22)
Psychedelics (12)
Radiopharmaceuticals (92)
Rare diseases (78)
Real estate (935)
Recruiting (7)
Regulatory (5025)
Reports (8)
Research institute (189)
Resumes & cover letters (6)
RSV (6)
Schizophrenia (37)
Series A (22)
Series B (17)
Service/supplier (1)
Sickle cell disease (5)
Southern California (802)
Spinal muscular atrophy (39)
Sponsored (1)
Startups (716)
State (1)
Supply chain (10)
Tariffs (3)
United States (7392)
Vaccines (91)
Venture capitalists (1)
Weight loss (13)
Women's health (1)
Date
Today (62)
Last 7 days (256)
Last 30 days (805)
Last 365 days (10032)
2025 (3187)
2024 (10760)
2023 (12376)
2022 (14248)
2021 (16016)
2020 (13734)
2019 (8861)
2018 (6260)
2017 (8083)
2016 (6583)
2015 (8401)
2014 (6331)
2013 (4529)
2012 (4458)
2011 (4457)
2010 (4477)
Location
Africa (81)
Alabama (14)
Arizona (19)
Arkansas (2)
Asia (11704)
Australia (1301)
California (2110)
Canada (475)
China (296)
Colorado (63)
Connecticut (79)
Delaware (75)
Europe (21512)
Florida (267)
Georgia (69)
Idaho (3)
Illinois (89)
India (6)
Indiana (64)
Iowa (2)
Japan (38)
Kansas (52)
Kentucky (7)
Maine (2)
Maryland (203)
Massachusetts (1644)
Michigan (31)
Minnesota (73)
Missouri (11)
Nebraska (5)
Nevada (3)
New Hampshire (2)
New Jersey (769)
New Mexico (4)
New York (742)
North Carolina (315)
Northern California (1032)
Ohio (55)
Oklahoma (3)
Oregon (9)
Pennsylvania (368)
Puerto Rico (1)
Rhode Island (3)
South America (125)
Southern California (802)
Tennessee (7)
Texas (196)
Utah (37)
Virginia (43)
Washington D.C. (9)
Washington State (111)
Wisconsin (7)
152,557 Results for "mapp biopharmaceutical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
DCN Dx and Mapp Biopharmaceutical Announce Subcontract
DCN Dx announced a subcontract with Mapp Biopharmaceutical, Inc., a developer of novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.
February 1, 2023
·
3 min read
Bio NC
KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment
KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment.
January 23, 2023
·
3 min read
Drug Development
MAPS PBC Announces Publication of Results from Confirmatory Phase 3 “MAPP2" Trial of MDMA-Assisted Therapy for PTSD in Nature Medicine
MAPS Public Benefit Corporation (“MAPS PBC”) announced that data from the company’s MAPP2 clinical trial, a multi-site Phase 3 study of MDMA-assisted therapy for post–traumatic stress disorder (“PTSD”), was published in the September issue of Nature Medicine.
September 14, 2023
·
11 min read
Business
Aridis Signs Exclusive Terms to Secure Worldwide Commercial Licenses for Pan-Ebola and Pan-Marburg Monoclonal Antibody Programs from Mapp Biopharmaceutical
Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, signed an exclusive term sheet to secure international development and global commercial rights upon licensure for the pan-Ebola and pan-Marburg monoclonal antibody (mAbs) programs from Mapp Biopharmaceutical, Inc.
December 5, 2022
·
9 min read
Press Releases
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
April 2, 2025
·
2 min read
Press Releases
Biopharmaceuticals Market Size Expected to Reach USD 1,796.21 Bn by 2034
February 17, 2025
·
1 min read
Press Releases
Biopharmaceutical Third Party Logistics Market Size to Surge USD 271.76 Billion by 2034
February 26, 2025
·
1 min read
Press Releases
Kangpu Biopharmaceuticals Received CDE Approval for Phase IIb Clinical Trial of KPG-818 in Moderate to Severe Cutaneous Manifestations of SLE
April 28, 2025
·
2 min read
Press Releases
HighField Biopharmaceuticals Files INDs for Two ADCplex™ Immunoliposomes with Different Cancer Killing Payloads to Overcome Limitations of Current ADCs
April 21, 2025
·
2 min read
Press Releases
Biopharmaceutical CMO and CRO Market Size to Worth USD 72.39 Bn by 2034
February 6, 2025
·
1 min read
1 of 15,256
Next
